(Q44203284)

30 November 2017

title

QSAR studies of HIV-1 integrase inhibition (English)

1 reference

30 November 2017

Hongbin Yuan

1

1 reference

30 November 2017

Abby L Parrill

series ordinal

2

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Bioorganic & Medicinal Chemistry

30 November 2017

published in

1 reference

30 November 2017

volume

10

1 reference

30 November 2017

issue

12

1 reference

30 November 2017

page(s)

4169-4183

1 reference

Progress in anti-HIV structure-based drug design

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Retroviral integrase, putting the pieces together

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Effects of Tyrphostins, Protein Kinase Inhibitors, on Human Immunodeficiency Virus Type 1 Integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Coumarin-based inhibitors of HIV integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Chicoric acid analogues as HIV-1 integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Potent inhibitors of human immunodeficiency virus type 1 integrase: identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Arylamide inhibitors of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Thiazolothiazepine inhibitors of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

The retroviral enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Retroviral integrases and their cousins

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

GA strategy for variable selection in QSAR studies: GA-based PLS analysis of calcium channel antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Traditional topological indices vs electronic, geometrical, and combined molecular descriptors in QSAR/QSPR research.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Active site binding modes of HIV-1 integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

A new class of HIV-1 integrase inhibitors: the 3,3,3', 3'-tetramethyl-1,1'-spirobi(indan)-5,5',6,6'-tetrol family

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900332-2

7 January 2021

10.1016/S0968-0896(02)00332-2

Identifiers

DOI

1 reference

30 November 2017

1 reference